Thaliporphine
From DrugPedia: A Wikipedia for Drug discovery
| Thaliporphine
| |
| Systematic (IUPAC) name | |
| N/A | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C20H23NO4 |
| Mol. mass | 341.40092 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
[edit] Description
from plant Neolitsea konishii K; potent agonist of vascular smooth muscle contractions in the presence of calcium; RN given refers to parent cpd (S)-isomer; RN for cpd without isomeric designation not avail 5/93
The present invention discloses thaliporphine and its derivatives for the treatment and/or prophylaxis of cardiac diseases, including cardiac arrhythmia, myocardial ischemia or myocardial infarction, and sudden death caused by cardiac arrhythmia or acute myocardial infarction.
[edit] General Properties
*Molecular Weight
341.40092
*Molecular Formula
C20H23NO4
*IUPAC NAME
N/A
*Canonical Smiles
CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC)O)OC
*Isomeric Smiles
N/A
*XLogP
2.6
*Topological Polar Surface Area
51.2
